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~GIOP~STY~ 
Loisance D. s Dubois-Rand6 S.L., Deleuze Ph., Okude J., 
obert T. Palac, H.D., 
Cachera J.P., Geschwind W.@ C.N.U. ~~NRI~~O~DOR~ Cretei.1, 
Parlsr France. 
F.A.C.C., Debra A. Angello, 
Sciences University, Portland, ii. 
F. .c.e. Oregon Health 
nary artery disease 
haIIium-201 (Tl- 
r. Other studies 
ion wftb late 
4-hr imaging. Therefore, we 
(4-hr) TI-201 imaging with 
ribose infusion more TI-20L rad~atr~butio~ 
than late (24-hr) imaging without rfbose infusion. Ten 
pts with CAD underwent two ~xe~~~ae Tl-2Ql stress tests, 
performed one to two weeks apart. After immediate post- 
exercise planar imaging, pts were randomized to receive 
either intravenous ribose (3.3 mg/kg/min) or an infusion 
of saline as a control for 30 minutes. Imaging was per- 
formed at 4 hr for the ribose study and at 24 hr for the 
safine control study. 
was carried to tke same 
ived the opposite infusion. Reversible Tf-201 
wero identified ~Uant~tat~v~Iy while bl%nded 
to the intervention. Four-hour post-exercise images after 
ribose infusion identified 20 not seen on the saline 
control study at 24 hr, only 5 were seen at 24 hr (in 
the saline control) but not with ribose st 4 hr (p-.005), 
and 7 were seen with both tests. In 8 of IO pts, addi- 
tional RD were seen after ribose infusion. We conclude 
that ribose accelerates Tl-201 redistribution at 4 hr 
compared to 24.hr control images in pts with CAD, and 
enhances the identification of ischsmic myacardium. 
ic of left ventricular (LV) mecha- 
nical support, based on an original intra-ventricular 
turbine (Hemopunpp Nimbus Inc.) has been used prophylacti- 
cally in high risk patients, selected for a PTCA. The 
pump achieoes a 2.5 - 3.5 l/min bypassed blood flow. Five 
patients, refused for CABG surgery because of major LV 
dysfunction (EF < 20 in 4)# previous surgery (in 3), 
and the culprit lesion on the only patent coronary vessel 
(in all) have been implanted with liemopumponehour prior 
PTCA. The pump was introduced via the femoral artery, 
exposed surgically under local anesthesia. Haemodynamica 
improved dramatically : 
CI (l/min/m’) PCWP (mmHg) 
pre assist 2.05 (1.5 - 2.4) 13 (7 _ 18) 
during assist 2.55 (2.4 - 2.7) 10 (7 - 13) 
PTCA could be performed successfully in all. Prolonged 
AV block (in l;, ventricular tachycardia (In 3) occurred 
during PTCA, without any clinical expression. No signifi- 
cant hemolysis was observed (plasma 
10 mg/dl). Patients were easily weaned of 
hour after dilatation. All patients could 
from ICU after two days. These immediate 
were confirmed in four patients9 after a follow-up 
ranging from 2 to 7 manths. 
These data show that Hemopump used prophylactically 
permits a safe PTCA in desperate ill,high risk patients. 
